INLFVSPACB• 6 Months (Normalized)
INLF vs PACB (INLIF LIMITED vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Apr 10 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
INLF Performance $3.44
-99.55%
INLIF LIMITED
Normalized Baseline0.00%
PACB Performance $2.7
+101.49%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
-201.04 pts
PACB outperforming by 201.04 percentage points
INLFPACB
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
INLF PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(122 dates)
| Date | INLF Price | INLF Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $3.44 | -99.55% | $2.70 | +101.49% | -201.04% |
| Oct 05, 2026 | $3.38 | -99.56% | $2.87 | +114.18% | -213.74% |
| Oct 02, 2026 | $3.55 | -99.54% | $2.54 | +89.55% | -189.09% |
| Oct 01, 2026 | $4.06 | -99.47% | $2.51 | +87.31% | -186.78% |
| Sep 30, 2026 | $4.08 | -99.47% | $2.37 | +76.87% | -176.34% |
| Sep 29, 2026 | $4.66 | -99.40% | $1.83 | +36.57% | -135.97% |
| Sep 28, 2026 | $5.23 | -99.32% | $1.71 | +27.61% | -126.93% |
| Sep 24, 2026 | $- | $1.46 | +8.58% | - | |
| Sep 23, 2026 | $2.91 | -99.62% | $1.41 | +5.22% | -104.84% |
| Sep 21, 2026 | $2.66 | -99.65% | $1.36 | +1.49% | -101.14% |
| Sep 18, 2026 | $2.69 | -99.65% | $1.37 | +2.24% | -101.89% |
| Sep 17, 2026 | $3.02 | -99.61% | $1.38 | +2.99% | -102.60% |
| Sep 16, 2026 | $2.94 | -99.62% | $1.34 | +0.00% | -99.62% |
| Sep 15, 2026 | $2.89 | -99.63% | $1.34 | +0.00% | -99.63% |
| Sep 14, 2026 | $2.96 | -99.62% | $1.35 | +0.75% | -100.37% |
Page 1 of 9